abstract |
The present invention is directed towards a process for resolving a racemic amino compound derived from dihydro- 1,3,5- triazines. The invention is also directed towards the enantiomers of amino derivatives of dihydro-1,3,5-triazines and to their use for the preparation of medicaments, in particular for the treatment of diabetes and malaria. |